A recent multiomics study integrating single-cell and bulk RNA sequencing with metabolomics revealed that SHMT1 expression declined with decreasing tumor differentiation, with significantly lower levels in anaplastic thyroid carcinoma (ATC) compared with PTC or normal tissue (Lee et al., 2024b). Here, SHMT1 is linked to neoplasm.